Page 3 - Medicare Benefit Policy Manual

50.4.3 - Examples of Not Reasonable and Necessary
50.4.4 - Payment for Antigens and Immunizations
50.4.4.1 - Antigens
50.4.4.2 - Immunizations
50.4.5 - Off Lable Use of Anti-Cancer Drugs and Biologicals

50.4.5.1 - Process for Amending the List of Compendia for
Determination of Medically-Accepted Indications for Off-Label
Uses of Drugs and Biologicals in an Anti-Cancer
Chemotherapeutic Regimen
50.4.6 - Less Than Effective Drug

50.4.7 - Denial of Medicare Payment for Compounded Drugs Produced in
Violation of Federal Food, Drug, and Cosmetic Act

50.4.8 - Process for Amending the List of Compendia for Determination
of Medically-Accepted Indications for Off-Label Uses of Drugs and
Biologicals in an Anti-Cancer Chemotherapeutic Regimen

50.5 - Self-Administered Drugs and Biologicals
50.5.1 - Immunosuppressive Drugs
50.5.2 - Erythropoietin (EPO)
50.5.2.1 - Requirements for Medicare Coverage for EPO
50.5.2.2 - Medicare Coverage of Epoetin Alfa (Procrit) for
Preoperative Use
50.5.3 - Oral Anti-Cancer Drugs
50.5.4 - Oral Anti-Nausea (Anti-Emetic) Drugs
50.5.5 - Hemophilia Clotting Factors
50.6 - Coverage of Intravenous Immune Globulin for Treatment of Primary
Immune Deficiency Diseases in the Home

60 - Services and Supplies
60.1 - Incident To Physician’s Professional Services
60.2 - Services of Nonphysician Personnel Furnished Incident To Physician’s
Services
60.3 - Incident To Physician’sServices in Clinic
60.4 - Services Incident to a Physician’s Service to Homebound Patients Under
General Physician Supervision
60.4.1 - Definition of Homebound Patient Under the Medicare Home
Health (HH) Benefit
70 - Sleep Disorder Clinics
80 - Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic
Tests
80.1 - Clinical Laboratory Services